Found 85 matching trials
Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS) PHASE2 The goal of this clinical research study is to compare how 2 different drug...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old PHASE1 A phase I-II trial based on the combination of three drugs regimen LDAC or ...
Show More Location
Hospital Universitario Príncipe de Asturias
Learn More & Join Trial
Open-label Study of FT-2102 With or Without Azacitidine or Cytarabine in Patients With AML or MDS With an IDH1 Mutation PHASE1 This Phase 1/2 study will evaluate the safety, efficacy, PK, and PD of FT-2...
Show More Location
UCLA Medical Center
Learn More & Join Trial
Venetoclax in Combination With Cladribine and Cytarabine Alternating With Azacitidine Plus Venetoclax for the Treatment of Newly Diagnosed Monocytic AML and Active Signaling Mutated AML PHASE2 This phase II trial tests how well venetoclax with cladribine and cytarabin...
Show More Location
University of Miami Miller School of Medicine-Sylvester Cancer Center
Learn More & Join Trial
Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD2811 Nanoparticles as Monotherapy or in Combination in Acute Myeloid Leukemia Participants. PHASE1 This is a Phase I/II clinical study to determine the maximum tolerated dose...
Show More Learn More & Join Trial
Low-Dose Decitabine in Myelodysplastic Syndrome Post Azacytidine Failure PHASE2 To study if decitabine can help to control Myelodysplastic Syndrome (MDS) i...
Show More Location
UT MD Anderson Cancer Center
Learn More & Join Trial
Azacytidine and Valproic Acid in Patients With Advanced Cancers PHASE1 Primary Objective:
1\. To evaluate side effects and maximum tolerated dose...
Show More Location
U.T.M.D. Anderson Cancer Center
Learn More & Join Trial
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML PHASE3 A randomized,multicenter, open-label Phase III, clinical study is conducted...
Show More Location
the First Affiliated Hospital,College of Medicine,Zhejiang University
Learn More & Join Trial
A Trial of Epigenetic Priming in Patients With Newly Diagnosed Acute Myeloid Leukemia PHASE2 The overall aim of this study is to determine if epigenetic priming with a ...
Show More Status
Active Not Recruiting
Location
Children's Hospital of Central California
Learn More & Join Trial
Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML PHASE2 This phase II trial tests how well VA alternating with low-dose CHA works i...
Show More Location
Beijing Chao-Yang Hospital, Capital Medical University
Learn More & Join Trial